LO SCALPELLO-OTODI Educational

, Volume 30, Issue 2, pp 127–131 | Cite as

La sindrome algodistrofica o Complex Regional Pain Syndrome type 1

Aggiornamenti
  • 149 Downloads

Complex regional pain syndrome type 1

Abstract

Complex regional pain syndrome (CRPS) includes a wide range of conditions affecting a peripheral limb characterised by chronic disabling pain that is seemingly disproportionate in time or degree to the usual course of any known trauma or other lesion. Pain is regional and it is typically associated with abnormal sensory, motor, sudomotor, vasomotor and/or trophic findings. The pathophysiology is still poorly understood. The disease shows a female preponderance with a peak age of incidence around the 5th and 6th decade. The available diagnostic criteria for CRPS-I rely exclusively on clinical criteria, that are unfortunately focused on the signs and symptoms of the chronic and late disease, while little emphasis is given to the typical imaging (X-rays, bone scintigraphy, MRI) findings of the early phase. Over the last decades, several therapies have been proposed but the few studies available are often too small to be conclusive and rarely evolved to randomised controlled trials (RCTs). On the basis of the results of a few RCTs, only bisphosphonate therapy appears to provide substantial benefits, especially in patients in the early phase of the disease, often leading to persistent remission or complete healing. In conclusion, short courses of high doses of bisphosphonates should be considered the treatment of choice for patients with CRPS-I.

Notes

Conflitto di interesse

Gli autori Davide Gatti, Angelo Fassio e Francesco Bertoldo dichiarano di non avere alcun conflitto di interesse.

Consenso informato e conformità agli standard etici

Tutte le procedure descritte nello studio e che hanno coinvolto esseri umani sono state attuate in conformità alle norme etiche stabilite dalla dichiarazione di Helsinki del 1975 e successive modifiche. Il consenso informato è stato ottenuto da tutti i pazienti inclusi nello studio.

Human and animal rights

L’articolo non contiene alcuno studio eseguito su esseri umani e su animali da parte degli autori.

Bibliografia

  1. 1.
    Merskey H, Bogduk N (eds) (1994) Classification of chronic pain syndromes and definition of terms. IASP press, Seattle Google Scholar
  2. 2.
    Harden RN, Bruehl S, Perez RS et al. (2010) Validation of proposed diagnostic criteria (the “Budapest criteria”) for complex regional pain syndrome. Pain 150:268–274 CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Marinus J, Moseley GL, Birklein F et al. (2011) Clinical features and pathophysiology of complex regional pain syndrome. Lancet Neurol 10:637–648 CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Sandroni P, Benrud-Larson LM, McClelland RL, Low PA (2003) Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population based study. Pain 103:199–207 CrossRefPubMedGoogle Scholar
  5. 5.
    de Mos M, de Bruijn AG, Huygen FJ et al. (2007) The incidence of complex regional pain syndrome: a population-based study. Pain 129:12–20 CrossRefPubMedGoogle Scholar
  6. 6.
    Sabsovich I, Guo TZ, Wei T et al. (2008) TNF signaling contributes to the development of nociceptive sensitization in a tibia fracture model of complex regional pain syndrome type I. Pain 137:507–519 CrossRefPubMedGoogle Scholar
  7. 7.
    Harden RN (2011) Cytokine imbalance/activity as a unifying hypothesis for the pathogenesis and pathophysiology of complex regional pain syndrome? Pain 152:247–248 CrossRefPubMedGoogle Scholar
  8. 8.
    Kingery WS (2010) Role of neuropeptide, cytokine, and growth factor signaling in complex regional pain syndrome. Pain Med 11:1239–1250 CrossRefPubMedGoogle Scholar
  9. 9.
    Field J (2013) Complex regional pain syndrome: a review. J Hand Surg Eur 38:616–626 CrossRefGoogle Scholar
  10. 10.
    McCabe CS, Blake DR (2008) An embarrassment of pain perceptions? Toward an understanding of and explanation for the clinical presentation of CRPS type I. Rheumatology 47:1612–1616 CrossRefPubMedGoogle Scholar
  11. 11.
    de Tran QH, Duong S, Bertini P, Finlayson RJ (2010) Treatment of complex regional pain syndrome: a review of the evidence. Can J Anesth 57:149–166 CrossRefPubMedGoogle Scholar
  12. 12.
    Perez RS, Zollinger PE, Dijkstra PU et al. (2010) Evidence based guidelines for complex regional pain syndrome type 1. BMC Neurol 10:20 CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Cossins L, Okell RW, Cameron H et al. (2013) Treatment of complex regional pain syndrome in adults: a systematic review of randomized controlled trials published from June 2000 to February 2012. Eur J Pain 17:158–173 CrossRefPubMedGoogle Scholar
  14. 14.
    Kiralp MZ, Yildiz S, Vural D et al. (2004) Effectiveness of hyperbaric oxygen therapy in the treatment of complex regional pain syndrome. J Int Med Res 32:258–262 CrossRefPubMedGoogle Scholar
  15. 15.
    Fleisch H (1982) Bisphosphonates: mechanisms of action and clinical applications. In: Peck WA (ed) Bone and mineral research, Annual 1. Excerpta Medica, Amsterdam, pp 319–537 Google Scholar
  16. 16.
    Cecchini MG, Fleisch H (1990) Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineage. J Bone Miner Res 5:1019–1027 CrossRefPubMedGoogle Scholar
  17. 17.
    Moreau MF, Guillet C, Massin P et al. (2007) Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro. Biochem Pharmacol 73:718–723 CrossRefPubMedGoogle Scholar
  18. 18.
    Adami S, Fossaluzza V, Gatti D et al. (1997) Bisphosphonate therapy of reflex sympathetic dystrophy syndrome. Ann Rheum Dis 56:201–204 CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Manicourt DH, Brasseur JP, Boutsen Y et al. (2004) Role of alendronate in therapy for posttraumatic complex regional pain syndrome type I of the lower extremity. Arthritis Rheumatol 50:3690–3697 CrossRefGoogle Scholar
  20. 20.
    Robinson JN, Sandom J, Chapman PT (2004) Efficacy of pamidronate in complex regional pain syndrome type I. Pain Med 5:276–280 CrossRefPubMedGoogle Scholar
  21. 21.
    Breuer B, Pappagallo M, Ongseng F et al. (2008) An open-label pilot trial of ibandronate for complex regional pain syndrome. Clin J Pain 24:685–689 CrossRefPubMedGoogle Scholar
  22. 22.
    Varenna M, Zucchi F, Ghiringhelli D et al. (2000) Intravenous clodronate in the treatment of reflex sympathetic dystrophy syndrome. A randomized, double blind, placebo controlled study. J Rheumatol 27:1477–1483 PubMedGoogle Scholar
  23. 23.
    Varenna M, Adami S, Rossini M et al. (2013) Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study. Rheumatology 52:534–542 CrossRefPubMedGoogle Scholar
  24. 24.
    Vande Berg BC, Lecouvet FE, Koutaissoff S et al. (2008) Bone marrow edema of the femoral head and transient osteoporosis of the hip. Eur J Radiol 67:68–77 CrossRefGoogle Scholar
  25. 25.
    Samdani A, Lachmann E, Nagler W (1998) Transient osteoporosis of the hip during pregnancy: a case report. Am J Phys Med Rehabil 77:153–156 CrossRefPubMedGoogle Scholar
  26. 26.
    La Montagna G, Malesci D, Tirri R, Valentini G (2005) Successful neridronate therapy in transient osteoporosis of the hip. Clin Rheumatol 24:67–69 CrossRefPubMedGoogle Scholar
  27. 27.
    Varenna M, Zucchi F, Binelli L et al. (2002) Intravenous pamidronate in the treatment of transient osteoporosis of the hip. Bone 31:96–101 CrossRefPubMedGoogle Scholar
  28. 28.
    Schapira D, Braun Moscovici Y, Gutierrez G, Nahir AM (2003) Severe transient osteoporosis of the hip during pregnancy. Successful treatment with intravenous biphosphonates. Clin Exp Rheumatol 21:107–110 PubMedGoogle Scholar

Copyright information

© Società Italiana Ortopedici Traumatologi Ospedalieri d’Italia 2016

Authors and Affiliations

  • Davide Gatti
    • 1
  • Angelo Fassio
    • 1
  • Francesco Bertoldo
    • 2
  1. 1.UOC di ReumatologiaAOUI di VeronaVeronaItalia
  2. 2.Centro Malattie Metaboliche dell’Osso, UOC Medicina Generale e Malattie Aterotrombotiche e DegenerativeAOUI di VeronaVeronaItalia

Personalised recommendations